Francesco Maura

66PUBLICATIONS

372CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Cancer diagnosisHaematological tumoursPredictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (66)

Sort by Publication Date:

|Jul 07, 2026

Concurrent administration of BCMA and GPRC5D chimeric antigen receptor (CAR) T cells in advanced multiple myeloma.

|Jun 12, 2026

Genomic features do not account for differences in multiple myeloma risk by ancestry.

|Jun 03, 2026

Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.

|May 01, 2026

A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients.

|Apr 12, 2026

Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

|Feb 17, 2026

IMS-IMWG 2025 consensus genomic staging predicts outcomes with daratumumab-based quadruplet regimens for NDMM.

Kylee H Maclachlan, Carlyn Rose Tan, Tala Shekarkhand

Pageof 11

Frequent Collaborators

43 joint publications

Ola Landgren

24 joint publications

Benjamin T Diamond

21 joint publications

Kylee Maclachlan

16 joint publications

Gareth Morgan

13 joint publications

Malin L Hultcrantz

12 joint publications

Ahmet Dogan

12 joint publications

Urvi Shah

11 joint publications

Saad Z Usmani

9 joint publications

Peter Leif Bergsagel